A Top 5 consumer health company has pledged to meet all safety and environmental standards while maintaining the efficacy that their brand has historically delivered. Accomplishing this will require reformulation of more than 200 consumer products within 2 years, without affecting the brand image.
The biopharmaceutical industry faces a daunting challenge to ensure the safety and efficacy of its products. Although some biopharmaceutical companies continue to perform safety surveillance internally, the trend is toward outsourcing drug safety operations.
Follow iMEDGlobal on LinkedIn for the latest on global product development. Read breaking stories, editorials by key opinion leaders, and articles by and/or about iMEDGlobal.